U.S. markets closed

Merck & Co., Inc. (MRK)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
92.08+0.68 (+0.74%)
At close: 04:03PM EDT
92.10 +0.02 (+0.02%)
After hours: 07:51PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Short-term KST

Short-term KST

Previous Close91.40
Bid91.80 x 1400
Ask92.12 x 800
Day's Range91.50 - 93.02
52 Week Range70.89 - 95.72
Avg. Volume10,539,798
Market Cap233.264B
Beta (5Y Monthly)0.32
PE Ratio (TTM)13.99
EPS (TTM)6.58
Earnings DateOct 27, 2022
Forward Dividend & Yield2.76 (3.03%)
Ex-Dividend DateSep 14, 2022
1y Target Est100.68
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Near Fair Value
7% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for MRK

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Merck & Company, Inc.
    Analyst Report: Merck & Co IncMerck & Co. is a worldwide pharmaceutical company. Its major drugs include treatments in oncology and diabetes. The company also has a leading vaccine business and an animal health division. MRK shares are included in the S&P 500.
    Fair Value
    Economic Moat
    10 days agoArgus Research
View more